Finance
Markets
No recent trading data. The last price we hold for DHR is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

DHR

stock Healthcare Diagnostics & Research
Danaher Corporation
$178.08 +1.97 (+1.12%) Delayed · quoted 46d ago
Concerning 37% Slipping

What the indicators say

Mixed 2 of 5 trend signals bullish
Momentum · RSI 14 Neutral
53
0oversold 30overbought 70100

RSI 53 — momentum is balanced between buyers and sellers.

EMA 21 $175.43
Above
Near-term trend is up
SMA 50 $181.08
Below
Medium-term trend is down
SMA 200 $205.61
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $166.07
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $173.63 High $178.54
Open
$178.11
+1.14%
Close
$178.11
+1.14%
52-week range where the price sits across its year
52w low $160.93 52w high $242.80
Current
$178.11
Prev close
$176.11
Volume 0.51× the 3-month average
0 avg 2× avg
Today
2.27M
3-mo avg
4.48M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 2191 days ago
Next expected
Jul 21in 0 days

Recent earnings dates

  • Apr 21 91 days ago
  • Jan 28 174 days ago
  • Jan 12 190 days ago
  • Oct 21, 2025 273 days ago

Past earnings dates come from DHR’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 53d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), DHR’s fundamentals read as fair overall.

P/E ratio Fair
34.4x

At 34.4x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.00%

This company pays no dividend, common for firms reinvesting their profits back into growth.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
14.7%

A 14.7% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
6.9%

A 6.9% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
4.3%

A 4.3% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
1.87

At 1.87, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+2.9%

Revenue grew 2.9% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-7.3%

Net income fell 7.3% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 53d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $24.8B$26.6B$23.9B$23.9B$24.6B
Net income $6.4B$7.2B$4.8B$3.9B$3.6B
Diluted EPS $8.61$9.66$6.38$5.29$5.05
Dividend / share
Total assets $83.2B$84.3B$84.5B$77.5B$83.5B
Total liabilities
Shareholder equity $45.2B$50.1B$53.5B$49.5B$52.5B

Leadershipsynced from SEC 59d ago

  • Blair Rainer President & CEO · Director
  • Gugino Matthew E EVP & Chief Financial Officer
  • Bouda Christopher VP, Chief Accounting Officer
  • Couchara Georgeann SVP, Human Resources
  • Gray R Bradley SVP Strategic Development
  • Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer
  • Leiken Jonathan SVP-Chief Legal Officer
  • Mcgrew Matthew Executive Vice President
  • Milosevich Gregory M Executive Vice President
  • Rales Mitchell P Chairman of Exec. Committee · Director
  • Riley Christopher Paul Executive Vice President
  • Sawyer Montgomery Julie A Executive Vice President
  • Dewan Feroz Director
  • Filler Linda Director
  • Lamanna Charles W Director
  • List Teri Director
  • Sanders A Shane Director
  • Spoon Alan G Director
  • Stevens Raymond C Director
  • Zerhouni Elias A. Director

Officers and board are drawn from DHR’s recent SEC ownership filings (Forms 3, 4 and 5).

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$1.28
2026 so far
$0.401 payment
2026 projected
$1.60+25.0% vs 2025

Projection scales DHR’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Mar 27 $0.40
  • Dec 26, 2025 $0.32
  • Sep 26, 2025 $0.32
  • Jun 27, 2025 $0.32
  • Mar 28, 2025 $0.32
  • Dec 27, 2024 $0.27
  • Sep 27, 2024 $0.27
  • Jun 28, 2024 $0.27
  • Mar 27, 2024 $0.27
  • Dec 28, 2023 $0.24
  • Oct 11, 2023 $0.27
  • Jun 29, 2023 $0.24
  • Mar 30, 2023 $0.24
  • Dec 29, 2022 $0.22
  • Sep 29, 2022 $0.22
  • Jun 23, 2022 $0.22
  • Mar 24, 2022 $0.22
  • Dec 29, 2021 $0.19
  • Sep 29, 2021 $0.19
  • Jun 24, 2021 $0.19

Recent SEC filingssynced from SEC 53d ago